Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Adamas Pharmaceuticals Inc
Adamas Pharmaceuticals Inc A Delaware Corporation
  

Adamas Pharmaceuticals Inc patents

Recent patent applications related to Adamas Pharmaceuticals Inc. Adamas Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Adamas Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Adamas Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Adamas Pharmaceuticals Inc-related inventors




Date Adamas Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
07/06/17Methods and compositions for the treatment of seizure-related disorders
06/01/17Amantadine compositions and methods of use
06/01/17Amantadine compositions and methods of use
06/01/17Amantadine compositions and methods of use
06/01/17Amantadine compositions and methods of use
06/01/17Amantadine compositions and methods of use
06/01/17Composition and treating neurological disease
06/01/17Composition and treating neurological disease
06/01/17Amantadine compositions and methods of use
03/02/17Composition for administering an nmda receptor antagonist to a subject
09/15/16Composition and treating neurological disease
09/15/16Amantadine compositions and methods of use
09/15/16Amantadine compositions and methods of use
09/15/16Amantadine compositions and methods of use
09/15/16Amantadine compositions and methods of use
09/15/16Composition and treating neurological disease
09/08/16Composition and treating neurological disease
09/08/16Amantadine compositions and methods of use
09/01/16Compositions for the treatment of cns-related conditions
09/01/16Compositions for the treatment of cns-related conditions
08/25/16Compositions for the treatment of cns-related conditions
08/25/16Compositions for the treatment of cns-related conditions
08/25/16Compositions for the treatment of cns-related conditions
08/25/16Compositions for the treatment of cns-related conditions
08/25/16Compositions for the treatment of cns-related conditions
08/11/16Methods of administering amantadine compositions
08/04/16Compositions for the treatment of cns-related conditions
06/02/16Amantadine compositions and methods of use
10/22/15Compositions for the treatment of cns-related conditions
06/11/15Composition and treating neurological disease
05/07/15Composition and treating neurological disease
05/07/15Composition and treating neurological disease
04/30/15Composition and treating neurological disease
03/26/15Methods of administering amantadine
02/26/15Amantadine compositions and methods of use
02/19/15Amantadine compositions and methods of use
02/12/15Amantadine compositions and methods of use
02/12/15Amantadine compositions and methods of use
02/12/15Amantadine compositions and methods of use
02/12/15Amantadine compositions and methods of use
02/12/15Amantadine compositions and methods of use
11/13/14Method for administering an nmda receptor antagonist to a subject
08/28/14Amantadine compositions and methods of use
06/26/14Composition for administering an nmda receptor antagonist to a subject
05/15/14Method for administering an nmda receptor antagonist to a subject
11/28/13Composition and treating neurological disease
06/27/13Composition and treating neurological disease
06/27/13Method for administering an nmda receptor antagonist to a subject
05/23/13Compositions for the treatment of cns-related conditions
11/15/12Methods for the treatment of cns-related conditions
10/18/12Compositions for the treatment of cns-related conditions
10/18/12Methods for the treatment of cns-related conditions
10/18/12Composition for administering an nmda receptor antagonist to a subject
03/08/12Method and composition for administering an nmda receptor antagonist to a subject
02/23/12Method and composition for administering an nmda receptor antagonist to a subject
02/23/12Method and composition for administering an nmda receptor antagonist to a subject
09/22/11Compositions and kits for treating influenza
08/04/11Amantadine compositions and methods of use
03/17/11Methods and compositions for the treatment of cns-related conditions
03/10/11Method and composition for administering an nmda receptor antagonist to a subject
12/09/10Methods and compositions for the treatment of cns-related conditions
11/18/10Methods and compositions for the treatment of psychiatric conditions
10/21/10Method and composition for administering an nmda receptor antagonist to a subject
10/14/10Method and composition for administering an nmda receptor antagonist to a subject
02/25/10Method and composition for administering an nmda receptor antagonist to a subject
Patent Packs
10/01/09Compositions and kits for treating influenza
10/18/12Method for administering an nmda receptor antagonist to a subject







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Adamas Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Adamas Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';